Independent Portfolio Consultants Lowers stake in Centene Corp (CNC)

Centene Corp (CNC) : Independent Portfolio Consultants reduced its stake in Centene Corp by 18.56% during the most recent quarter end. The investment management company now holds a total of 37,113 shares of Centene Corp which is valued at $2,174,822 after selling 8,460 shares in Centene Corp , the firm said in a disclosure report filed with the SEC on Apr 13, 2016.Centene Corp makes up approximately 0.60% of Independent Portfolio Consultants’s portfolio.

Centene Corp opened for trading at $58.6 and hit $59.76 on the upside on Monday, eventually ending the session at $59.39, with a gain of 1.35% or 0.79 points. The heightened volatility saw the trading volume jump to 17,91,631 shares. Company has a market cap of $7,225 M.

Other Hedge Funds, Including , Santa Fe Partners added CNC to its portfolio by purchasing 39,213 company shares during the most recent quarter which is valued at $2,297,882. Centene Corp makes up approx 0.37% of Santa Fe Partners’s portfolio.Central Trust Co reduced its stake in CNC by selling 91 shares or 1.36% in the most recent quarter. The Hedge Fund company now holds 6,604 shares of CNC which is valued at $386,994. Centene Corp makes up approx 0.03% of Central Trust Co’s portfolio.Dnb Asset Management As reduced its stake in CNC by selling 85,000 shares or 46.83% in the most recent quarter. The Hedge Fund company now holds 96,500 shares of CNC which is valued at $5,654,900. Centene Corp makes up approx 0.12% of Dnb Asset Management As’s portfolio. Pensionfund Dsm Netherlands added CNC to its portfolio by purchasing 50,000 company shares during the most recent quarter which is valued at $2,971,500. Centene Corp makes up approx 0.41% of Pensionfund Dsm Netherlands’s portfolio. Pensionfund Sabic added CNC to its portfolio by purchasing 24,000 company shares during the most recent quarter which is valued at $1,426,320. Centene Corp makes up approx 0.44% of Pensionfund Sabic’s portfolio.

On the company’s financial health, Centene Corp reported $0.95 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $0.95. The company had revenue of $6302.00 million for the quarter, compared to analysts expectations of $6318.11 million. The company’s revenue was up 33.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.63 EPS.

Many Wall Street Analysts have commented on Centene Corp. Shares were Reiterated by Barclays on Feb 10, 2016 to “Equal Weight” and Lowered the Price Target to $ 64 from a previous price target of $72 .

Centene Corporation is a healthcare company. The Company provides programs and services to Government sponsored healthcare programs. It offers member-focused services by assisting in accessing care coordinating referrals to related health and social services and addressing member concerns and questions. It also provides education and outreach programs to inform and assist members in accessing healthcare services. The Company operates in two segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Government subsidized programs including Medicaid the State Children’s Health Insurance Program (CHIP) Long Term Care (LTC) Foster Care dual-eligible individuals (Duals) and the Supplemental Security Income Program also known as the Aged Blind or Disabled Program (ABD). The Specialty Services segment consists of the Company’s specialty companies offering auxiliary healthcare services and products.

Leave a Reply

Centene Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Centene Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.